Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range
Go back to Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range| VALEANT PHARMACEUTICALS INTERNATIONAL (NYSE: VRX) | Delayed: 23.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.40 | 52 Week High | $119.86 | |||
| Open | $23.40 | 52 Week Low | $13.77 | |||
| Day High | $23.40 | P/E | N/A | |||
| Day Low | $23.40 | EPS | $0.00 | |||
| Volume | 378,733 | |||||
| VALEANT PHARMACEUTICALS INTERNATIONAL (NYSE: VRX) | Delayed: 23.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.40 | 52 Week High | $119.86 | |||
| Open | $23.40 | 52 Week Low | $13.77 | |||
| Day High | $23.40 | P/E | N/A | |||
| Day Low | $23.40 | EPS | $0.00 | |||
| Volume | 378,733 | |||||
